GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » EV-to-EBITDA

BioNeutra Global (TSXV:BGA) EV-to-EBITDA : -28.21 (As of May. 24, 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioNeutra Global's enterprise value is C$9.93 Mil. BioNeutra Global's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.35 Mil. Therefore, BioNeutra Global's EV-to-EBITDA for today is -28.21.

The historical rank and industry rank for BioNeutra Global's EV-to-EBITDA or its related term are showing as below:

TSXV:BGA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3239.72   Med: 0.01   Max: 62.62
Current: -28.21

During the past 13 years, the highest EV-to-EBITDA of BioNeutra Global was 62.62. The lowest was -3239.72. And the median was 0.01.

TSXV:BGA's EV-to-EBITDA is ranked worse than
100% of 1546 companies
in the Consumer Packaged Goods industry
Industry Median: 10.74 vs TSXV:BGA: -28.21

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), BioNeutra Global's stock price is C$0.09. BioNeutra Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.060. Therefore, BioNeutra Global's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


BioNeutra Global EV-to-EBITDA Historical Data

The historical data trend for BioNeutra Global's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global EV-to-EBITDA Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.08 -9.84 -12.51 -5.30 -18.97

BioNeutra Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.30 -3.02 -3.21 -2.59 -18.97

Competitive Comparison of BioNeutra Global's EV-to-EBITDA

For the Packaged Foods subindustry, BioNeutra Global's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's EV-to-EBITDA falls into.



BioNeutra Global EV-to-EBITDA Calculation

BioNeutra Global's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9.931/-0.352
=-28.21

BioNeutra Global's current Enterprise Value is C$9.93 Mil.
BioNeutra Global's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNeutra Global  (TSXV:BGA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BioNeutra Global's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.09/-0.060
=At Loss

BioNeutra Global's share price for today is C$0.09.
BioNeutra Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


BioNeutra Global EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global (TSXV:BGA) Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

BioNeutra Global (TSXV:BGA) Headlines

No Headlines